We are pleased to announce the launch of a new CorEvitas clinical registry and biorepository in Systemic Lupus Erythematosus (SLE). This registry, which is open for enrollment, addresses an unmet need for real-world evidence (RWE) related to the clinician- and patient-reported outcomes of patients with SLE.
The new registry collects deep regulatory-grade longitudinal clinical data from enrolled patients and their treating physicians across multiple health outcome domains, including treatment utilization, quality of life, disease activity and severity, medical comorbidities, diagnostic tests and adverse events.
Read the press release, here.
Find out more about the registry, including how to enroll, here.